Search - tctmd.com

Displaying 761 - 780 of 2228

Sort: Relevancy | Date

Presentation EuroPCR 2015

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Presenter: Masahiro Natsuaki

May 19, 2015

Presentation EuroPCR 2015

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Presenter: Sigmund Silber

May 19, 2015

News Industry News

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

May 19, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

Presentation Fellows 2015

Drug-Eluting Stents: Past, Present, and Future

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

News Industry News

Medtronic Receives FDA Approval and CE Mark for Arctic Front Advance® ST Cryoballoon to Treat Atrial Fibrillation

May 12, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Industry News

India Coronary Stent Market to be Tripled by 2021

May 05, 2015

News Industry News

NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting

May 04, 2015

News Daily News

积极准备下钙化灶 BRS 置入可行

April 29, 2015

News Daily News

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

April 29, 2015

News Daily News

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

April 29, 2015

News Industry News

STENTYS' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan

April 28, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

Presentation ARCH 2015

Below the Knee Stenting

Presenter: George S. Chrysant

April 10, 2015

Presentation ARCH 2015

How to Approach In-Stent Restenosis

Presenter: Craig M. Walker

April 10, 2015

Presentation ARCH 2015

DEB - BVS

Presenter: George S. Chrysant

April 10, 2015

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

Advertisement

Final Three-Year Outcome of a Randomized Trial Comparing Second Generation DES Using Either Biodegradable Polymer or Durable Polyme

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

Drug-Eluting Stents: Past, Present, and Future

Medtronic Receives FDA Approval and CE Mark for Arctic Front Advance® ST Cryoballoon to Treat Atrial Fibrillation

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

India Coronary Stent Market to be Tripled by 2021

NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting

积极准备下钙化灶 BRS 置入可行

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

BRS Use in Calcified Lesions Feasible With Aggressive Preparation

STENTYS' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

Below the Knee Stenting

How to Approach In-Stent Restenosis

DEB - BVS

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content